Bank on These 2 Safe Healthcare Stocks in Crazy Times
Amid a global health crisis and a very uncertain market, safe healthcare stocks should be part of your portfolio. Here are two that stand out.
Read More
Amid a global health crisis and a very uncertain market, safe healthcare stocks should be part of your portfolio. Here are two that stand out.
Read More
While biotech shares have been pressured of late, this fund is entering its historically best season.
Read More
Buying biotech stocks seems like a contrarian play at the moment. But it made one day trader a lot of money. Here's what it says about the current market.
Read More
Most biotechs have been red-hot, but Teva Pharmaceuticals (TEVA) just fell 40% in three days. Here's what happened to TEVA stock.
Read More
Biotech stocks shot up 9.5% last week, and some stocks much more than that. That makes the sector a great place for short-term momentum plays.
Read More
The Chicago Board of Options Exchange Volatility Index (VIX) closed the week at 11.49, marginally higher on the week. This was interesting price action as the market was making new highs and ahead of a long weekend (would have expected new lows).
Read More
The Chicago Board of Options Exchange Volatility Index (VIX) closed the week at 11.49, marginally higher on the week. This was interesting price action as the market was making new highs and ahead of a long weekend (would have expected new lows).
Read More
The six-year rally in biotech stocks has come to an end, but that doesn't mean there aren't a few biotechs worth buying. One of them has doubled since June.
Read More